$1.9 B

AERI Mkt cap, 04-Dec-2018

$7.3 M

Aerie Pharmaceuticals Revenue Q3, 2018
Aerie Pharmaceuticals Gross profit (Q3, 2018)7.1 M
Aerie Pharmaceuticals Gross profit margin (Q3, 2018), %97.2%
Aerie Pharmaceuticals Net income (Q3, 2018)-85.4 M
Aerie Pharmaceuticals EBIT (Q3, 2018)-61.3 M
Aerie Pharmaceuticals Cash, 30-Sep-2018235 M

Aerie Pharmaceuticals Income Statement

Aerie Pharmaceuticals Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

69.6m85.6m91.1m197.9m197.6m

Accounts Receivable

399.0m

Inventories

618.0k1.1m1.9m4.0m

Current Assets

70.3m141.0m138.4m237.7m254.1m

PP&E

31.9m

Total Assets

70.5m161.1m159.1m248.3m290.3m

Accounts Payable

3.5m551.0k551.0k551.0k6.2m

Current Liabilities

3.5m8.9m17.1m19.4m25.2m

Total Liabilities

142.9m154.7m

Additional Paid-in Capital

162.0m171.3m236.5m422.0m597.3m

Retained Earnings

(143.2m)(217.6m)(316.6m)(461.7m)

Total Equity

67.0m18.8m105.3m135.6m

Financial Leverage

1.1 x8.5 x2.4 x2.1 x

Aerie Pharmaceuticals Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(31.1m)(48.1m)(74.4m)(99.1m)(145.1m)

Depreciation and Amortization

64.0k73.0k252.0k970.0k1.4m

Accounts Payable

2.0m551.0k

Cash From Operating Activities

(16.4m)(33.7m)(55.7m)(79.8m)(93.2m)

Cash From Investing Activities

(63.0k)(73.3m)9.4m18.1m(42.8m)

Cash From Financing Activities

83.2m123.0m51.8m168.6m135.6m

Interest Paid

2.2m2.2m2.2m

Income Taxes Paid

600.0k1.8m

Aerie Pharmaceuticals Ratios

USDY, 2018

Financial Leverage

1.2 x
Report incorrect company information

Aerie Pharmaceuticals Employee Rating

5.01 votes
Culture & Values
5.0
Work/Life Balance
5.0
Senior Management
5.0
Salary & Benefits
5.0
Career Opportunities
5.0
Source